The directors of Paragon Care Limited announced that Mr. Andrew Just has commenced in his full-time role as Chief Executive Officer. In line with its stated strategy, Paragon continues to pursue strong organic and acquisitive growth while also driving returns from its existing portfolio of products and services. The successful transition of the Chief Executive Officer (CEO) role to Andrew is driven by, and is expected to support the compelling opportunities the Board sees for growth.

Andrew has 25 years of highly relevant global senior executive experience in the healthcare industry at Fortune 500 and ASX-listed companies including Stryker, Cochlear, GE Healthcare, Radiometer, Roche and Novartis. Mark Simari has resigned from his role as a director of the company, but remains with the company in a new role focused as head of mergers and acquisitions.